Literature DB >> 29064601

Differential involvement of nigral subregions in idiopathic parkinson's disease.

Young Hee Sung1, Jongho Lee2, Yoonho Nam3, Hyeong-Geol Shin2, Young Noh1, Dong Hoon Shin1, Eung Yeop Kim4.   

Abstract

In this study, the prevalence of abnormality in putative nigrosome 1 and nigrosome 4 (N1 and N4, respectively) was investigated in early versus late-stage idiopathic Parkinson's disease (IPD) patients. A total of 128 IPD patients (early stage[n = 89]; late stage[n = 39]) and 15 healthy subjects were scanned for high-resolution (0.5 × 0.5 × 1.0 mm3 ) multiecho gradient-recalled echo MRI and dopamine transporter PET imaging. The MRI data were processed for susceptibility map-weighted imaging (SMWI) to improve a contrast-to-noise ratio, and the images were resliced at 0.5 mm to define N1 and N4. When each side of N1 and N4 was assessed separately for the loss of hyperintensity by two independent reviewers, the consensus review results showed that in early-stage IPD (178 substantia nigras [SNs]), the loss of hyperintensity was observed more often in only the N1 region (65.2%) when compared to in both N1 and N4 regions (34.8%). In late-stage IPD (78 SNs), on the other hand, the loss in only the N1 region (25.6%) was less prevalent than in both N1 and N4 (74.4%) (P < 0.0001). Additionally, intact SNs (both in N1 and N4) were observed 17 SNs (9.6%) of the early-stage IPD patients, whereas it was not found in any SNs of the late-stage IPD patients (P = 0.005). Moreover, involvement of both N1 and N4 on both sides was found in 19.1% of the early-stage IPD patients, whereas its incidence was higher (61.5%) in the late-stage IPD patients (P < 0.0001), suggesting that the loss of hyperintensity in IPD progresses from N1 to N4 as the disease advances. Hum Brain Mapp 39:542-553, 2018.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Parkinson disease; magnetic resonance imaging; nigrosome; pars compacta; substantia nigra

Mesh:

Substances:

Year:  2017        PMID: 29064601      PMCID: PMC6866465          DOI: 10.1002/hbm.23863

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  30 in total

1.  The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method.

Authors:  B Pakkenberg; A Møller; H J Gundersen; A Mouritzen Dam; H Pakkenberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-01       Impact factor: 10.154

Review 2.  The discovery of dopamine deficiency in the parkinsonian brain.

Authors:  O Hornykiewicz
Journal:  J Neural Transm Suppl       Date:  2006

3.  Nigral involvement in atypical parkinsonisms: evidence from a pilot study with ultra-high field MRI.

Authors:  Daniela Frosini; Roberto Ceravolo; Michela Tosetti; Ubaldo Bonuccelli; Mirco Cosottini
Journal:  J Neural Transm (Vienna)       Date:  2016-03-04       Impact factor: 3.575

4.  MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease.

Authors:  Mirco Cosottini; Daniela Frosini; Ilaria Pesaresi; Mauro Costagli; Laura Biagi; Roberto Ceravolo; Ubaldo Bonuccelli; Michela Tosetti
Journal:  Radiology       Date:  2014-02-26       Impact factor: 11.105

5.  Drug-induced Parkinsonism versus Idiopathic Parkinson Disease: Utility of Nigrosome 1 with 3-T Imaging.

Authors:  Young Hee Sung; Young Noh; Jongho Lee; Eung Yeop Kim
Journal:  Radiology       Date:  2015-12-21       Impact factor: 11.105

6.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

7.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

Review 8.  Loss of Nigral Hyperintensity on 3 Tesla MRI of Parkinsonism: Comparison With (123) I-FP-CIT SPECT.

Authors:  Yun Jung Bae; Jong-Min Kim; Eunhee Kim; Kyung Mi Lee; Seo Young Kang; Hyun Soo Park; Kyeong Joon Kim; Young Eun Kim; Eung Seok Oh; Ji Young Yun; Ji Seon Kim; Hye-Jin Jeong; Beomseok Jeon; Sang Eun Kim
Journal:  Mov Disord       Date:  2016-03-17       Impact factor: 10.338

9.  Nigrosome-1 on Susceptibility Weighted Imaging to Differentiate Parkinson's Disease From Atypical Parkinsonism: An In Vivo and Ex Vivo Pilot Study.

Authors:  Frederick J A Meijer; Stefan C Steens; Anouke van Rumund; Anne-Marie van Cappellen van Walsum; Benno Küsters; Rianne A J Esselink; Marcel M Verbeek; Bastiaan R Bloem; Bożena Goraj
Journal:  Pol J Radiol       Date:  2016-08-03

10.  Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI.

Authors:  Anna I Blazejewska; Stefan T Schwarz; Alain Pitiot; Mary C Stephenson; James Lowe; Nin Bajaj; Richard W Bowtell; Dorothee P Auer; Penny A Gowland
Journal:  Neurology       Date:  2013-07-10       Impact factor: 9.910

View more
  8 in total

Review 1.  Nigrosome 1 imaging: technical considerations and clinical applications.

Authors:  Eung Yeop Kim; Young Hee Sung; Jongho Lee
Journal:  Br J Radiol       Date:  2019-06-05       Impact factor: 3.039

2.  Early-stage Parkinson's disease: Abnormal nigrosome 1 and 2 revealed by a voxelwise analysis of neuromelanin-sensitive MRI.

Authors:  Young Hee Sung; Young Noh; Eung Yeop Kim
Journal:  Hum Brain Mapp       Date:  2021-03-10       Impact factor: 5.038

3.  Pharmacokinetic Modeling of 18F-FDOPA PET in the Human Brain for Early Parkinson's Disease

Authors:  Wirunpatch Buratachwatanasiri; Maythinee Chantadisai; Jaruwan Onwanna; Yuda Chongpison; Yothin Rakvongthai; Kitiwat Khamwan
Journal:  Mol Imaging Radionucl Ther       Date:  2021-06-03

4.  Cortical thinning pattern according to differential nigrosome involvement in patients with Parkinson's disease.

Authors:  Na-Young Shin; Bo-Hyun Kim; Eunkyeong Yun; Uicheul Yoon; Jong-Min Lee; Young Hee Sung; Eung Yeop Kim
Journal:  Neuroimage Clin       Date:  2020-08-13       Impact factor: 4.881

5.  Fast 3 T nigral hyperintensity magnetic resonance imaging in Parkinson's disease.

Authors:  Gabriella Hernadi; David Pinter; Szilvia Anett Nagy; Gergely Orsi; Samuel Komoly; Jozsef Janszky; Norbert Kovacs; Gabor Perlaki
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

Review 6.  An Updated Overview of the Magnetic Resonance Imaging of Brain Iron in Movement Disorders.

Authors:  Nicola Tambasco; Pasquale Nigro; Andrea Chiappiniello; Federico Paolini Paoletti; Sara Scialpi; Simone Simoni; Pietro Chiarini; Lucilla Parnetti
Journal:  Behav Neurol       Date:  2022-02-24       Impact factor: 3.342

Review 7.  [MRI Findings in Parkinson's Disease: Radiologic Assessment of Nigrostriatal Degeneration].

Authors:  Yun Jung Bae; Jong-Min Kim; Byung Se Choi; Yoo Sung Song; Yoonho Nam; Se Jin Cho; Jae Hyoung Kim; Sang Eun Kim
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2022-05-25

Review 8.  Nigrosome Imaging and Neuromelanin Sensitive MRI in Diagnostic Evaluation of Parkinsonism.

Authors:  Nicola Pavese; Yen F Tai
Journal:  Mov Disord Clin Pract       Date:  2018-02-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.